Creative Medical taps CRO Syneos to run Type 1 diabetes cell therapy study
Biotech Creative Medical Technology has tapped Syneos to run a phase 1/2 randomized trial of its cell therapy for the potential treatment of Type …
See more –> Source
Posted ineHealth
Creative Medical taps CRO Syneos to run Type 1 diabetes cell therapy study
